Pharmafile Logo
Pharmafocus logo
Advanced Search
darren_taylor1

Living with multiple ‘invisible’ conditions

May 26, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing feature, patient experience, rare disease

Darren Taylor lives with a range of conditions including Dercum’s disease, cystic fibrosis, fibromyalgia with chronic fatigue, and Tietze syndrome, …

Feature
covid-19_vaccine

Scientists working on UK COVID-19 vaccine say there is now only a 50% chance of success due to falling cases

May 26, 2020
Manufacturing and Production COVID-19, coronavirus

Researchers working on a COVID-19 vaccine are facing a race against time due to falling rates of the virus threatening …

News
sonny

Hot and humid weather can slow COVID-19 transmission, new study finds

May 26, 2020
Manufacturing and Production COVID-19, coronavirus

A new study from the Massachusetts Institute of Technology, Harvard, Virginia Tech and the University of Connecticut has shown that …

News
fda

FDA approves Takeda’s first-line treatment option for non-small cell lung cancer

May 26, 2020
Manufacturing and Production FDA, Takeda, approval

The FDA has approved Takeda’s Alunbrig (brigatinib) for adult patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer …

News
49891315508_8849365d96_c

Cleaning staff excluded from GSK’s £1.5k COVID-19 employee bonus

May 26, 2020
Manufacturing and Production COVID-19, GSK, coronavirus, pharma

UK pharma giant GlaxoSmithKline has pledged to pay a cash bonus of £1,500 to staff continuing to work during the …

News
world

WHO stops hydroxychloroquine trial due to safety concerns

May 26, 2020
Manufacturing and Production COVID, COVID-19, coronavirus

The World Health Organization has announced it will stop a global study into the effectiveness of hydroxychloroquine in COVID-19 patients, …

News
4223373030_df7722f9f7_c

Harvard study suggests monkeys develop immunity after receiving COVID-19 vaccines

May 21, 2020
Research and Development COVID-19, vaccine coronavirus

“The COVID-19 pandemic has made the development of a safe, effective, and deployable vaccine a critical global priority”, said researchers …

News
uk_drox

UK begins hydroxychloroquine trial

May 21, 2020
Business Services COVID-19, coronavirus, hydroxychloroquine

A trial investigating the effectiveness of hydroxychloroquine against COVID-19 has begun in the UK. The first participants will be enrolled …

News
hand_washing

Two billion people are at high risk of contracting COVID-19 due to poor sanitation

May 21, 2020
Business Services COVID-19, coronavirus, sanitation

About a quarter of the world’s population are at higher risk of catching the COVID-19 coronavirus due to a lack …

News
sonny

Researchers plan to use machine learning methods to estimate the seasonal cycle of COVID-19 in the US

May 21, 2020
Business Services COVID-19, coronavirus

Scientists at the Lawrence Berkeley National Laboratory are launching a project to apply machine learning methods to map the severity, …

News
az_vaccine

AstraZeneca targets one billion COVID-19 vaccines by September

May 21, 2020
Business Services COVID-19, Vaccine, coronavirus, coronavirus vaccine

AstraZeneca is attempting to deliver one billion doses of coronavirus vaccine by September, which is currently being developed in collaboration …

News
covid

Pharmafile.com’s weekly COVID-19 news round-up

May 20, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Trump, coronavirus

Trump continues to play a key role in the unfolding COVID-19 pandemic, with the US currently coping with the largest …

News
mit

MIT-developed algorithm seeks to accelerate drug approvals during COVID-19 pandemic

May 20, 2020
Research and Development, Sales and Marketing COVID-19, MIT, coronavirus, regulatory

A study emerging from the Massachusetts Institute of Technology (MIT) and published in the Harvard Data Science Review has detailed strategies …

News
ai

New research outlines guidelines for the ethical use of AI in healthcare

May 20, 2020
Research and Development AI, coronavirus

A new study published in The Lancet has called on the global health community to establish guidelines to develop and …

News

Nanotechnology could be used to assess mortality risk in COVID-19 patients

May 20, 2020
Research and Development COVID-19, coronavirus, nanotechnology

Doctors could use nanotechnology to assess the morality risk from COVID-19, according to research from Michigan State University. Morteza Mahmoudi, …

News
diabetes_3

Type 1 diabetics more likely to die from COVID-19 than type 2, according to the NHS

May 20, 2020
Research and Development COVID-19, Diabetics, coronavirus, diabetes

People suffering type 1 diabetes are far more likely to die of coronavirus than those with type 2, according to …

News
moderna-605x340

Interim data for Moderna’s COVID-19 vaccine shows glimmers of hope

May 19, 2020
Manufacturing and Production, Research and Development COVID-19, Moderna, Vaccine, coronavirus, pharma

Biotech firm Moderna has unveiled interim data from its Phase 1 trial of mRNA-1273, its vaccine against SARS-CoV-2, the virus …

News
astrazeneca_sign_sky

AstraZeneca pledges to manufacture 30m units of Oxford University’s COVID-19 vaccine

May 19, 2020
Manufacturing and Production AstraZeneca, COVID-19, UK, Vaccine, coronavirus, pharma

AstraZeneca has provided an update on the partnership it forged with the University of Oxford in late April to push …

News
whitw_house

US threatens to permanently cut off WHO funding

May 19, 2020
Manufacturing and Production COVID-19, Trump, coronavirus

The US has threatened to permanently cut off funding to the World Health Organization if they do not take proposed …

News
drugs

Trump signs deal with generics company Phlow Corp to help shift drug manufacturing to the US

May 19, 2020
Manufacturing and Production APIs, COVID-19, Drugs manufacturing, coronavirus, generics

The Trump administration will sign a $354 million deal with the generics company Phlow Corp to help produce medicines and …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026